IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 141 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $694,882 | +16.1% | 72,158 | +28.3% | 0.00% | – |
| Q2 2023 | $598,532 | +3.8% | 56,253 | +2.6% | 0.00% | – |
| Q1 2023 | $576,738 | -14.5% | 54,823 | +0.7% | 0.00% | – |
| Q4 2022 | $674,660 | +19.4% | 54,452 | -0.1% | 0.00% | – |
| Q3 2022 | $564,827 | -11.5% | 54,520 | -1.5% | 0.00% | – |
| Q2 2022 | $637,920 | -15.7% | 55,327 | -8.0% | 0.00% | – |
| Q1 2022 | $756,347 | -13.1% | 60,123 | -19.4% | 0.00% | -100.0% |
| Q4 2021 | $870,000 | -12.2% | 74,628 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $991,000 | -6.2% | 75,908 | -7.5% | 0.00% | 0.0% |
| Q2 2021 | $1,057,000 | +4.1% | 82,099 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $1,015,000 | -7.0% | 90,763 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $1,091,000 | +30.3% | 95,781 | +2.9% | 0.00% | 0.0% |
| Q3 2020 | $837,000 | -13.8% | 93,105 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $971,000 | -2.7% | 95,343 | -3.6% | 0.00% | 0.0% |
| Q1 2020 | $998,000 | -19.3% | 98,888 | +6.5% | 0.00% | 0.0% |
| Q4 2019 | $1,236,000 | +47.0% | 92,878 | -3.4% | 0.00% | 0.0% |
| Q3 2019 | $841,000 | -20.4% | 96,103 | -0.4% | 0.00% | 0.0% |
| Q2 2019 | $1,056,000 | +1.1% | 96,510 | +4.6% | 0.00% | 0.0% |
| Q1 2019 | $1,045,000 | +15.7% | 92,294 | +6.0% | 0.00% | 0.0% |
| Q4 2018 | $903,000 | -46.0% | 87,097 | -3.9% | 0.00% | -50.0% |
| Q3 2018 | $1,672,000 | -14.9% | 90,585 | -11.9% | 0.00% | 0.0% |
| Q2 2018 | $1,965,000 | +26.6% | 102,797 | +2.3% | 0.00% | 0.0% |
| Q1 2018 | $1,552,000 | +0.1% | 100,509 | -2.9% | 0.00% | 0.0% |
| Q4 2017 | $1,550,000 | -4.7% | 103,462 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $1,626,000 | -17.6% | 103,131 | -1.4% | 0.00% | 0.0% |
| Q2 2017 | $1,974,000 | +14.7% | 104,571 | +3.6% | 0.00% | 0.0% |
| Q1 2017 | $1,721,000 | +26.8% | 100,890 | +13.7% | 0.00% | 0.0% |
| Q4 2016 | $1,357,000 | -4.2% | 88,761 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $1,416,000 | +21.5% | 89,177 | +0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,165,000 | +30.8% | 89,167 | +4.8% | 0.00% | +100.0% |
| Q1 2016 | $891,000 | -7.8% | 85,108 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $966,000 | +12.2% | 83,416 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $861,000 | -11.1% | 82,630 | +2.9% | 0.00% | 0.0% |
| Q2 2015 | $968,000 | -23.7% | 80,281 | +1.3% | 0.00% | -50.0% |
| Q1 2015 | $1,268,000 | +8.1% | 79,249 | +3.5% | 0.00% | 0.0% |
| Q4 2014 | $1,173,000 | +15.8% | 76,580 | -2.0% | 0.00% | +100.0% |
| Q3 2014 | $1,013,000 | -13.6% | 78,175 | +2.2% | 0.00% | -50.0% |
| Q2 2014 | $1,172,000 | +32.1% | 76,460 | +6.2% | 0.00% | +100.0% |
| Q1 2014 | $887,000 | +5.6% | 72,006 | -0.4% | 0.00% | 0.0% |
| Q4 2013 | $840,000 | -3.1% | 72,307 | -1.1% | 0.00% | 0.0% |
| Q3 2013 | $867,000 | +15.6% | 73,113 | -3.1% | 0.00% | 0.0% |
| Q2 2013 | $750,000 | – | 75,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |